Neko Health raises 700 million dollars to launch AI-driven body scanning clinics in the United States

1. Funding and Expansion

Neko Health has raised $700 million in a Series C funding round to support the expansion of its AI-driven body scanning services into the United States, beginning with a new clinic in New York. The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing investors including Atomico, General Catalyst, and Lakestar. New investors include Liberty City Ventures, Positive Sum, and BDT & MSD, alongside high-profile individual backers such as Mark Zuckerberg, Priscilla Chan, Maria Sharapova, will.i.am, and Thierry Henry. This latest investment brings the company’s total disclosed funding to over $1 billion since 2023.

2. Service Model and Technology

Founded in 2018 by Spotify co-founder Daniel Ek and CEO Hjalmar Nilsonne, Neko Health provides a 60-minute, non-invasive health assessment. The service utilizes proprietary sensors, medical imaging, and blood analysis to screen for conditions such as skin cancer, cardiovascular disease, and diabetes. The process includes an electrocardiogram, arterial measurements, and high-resolution skin mapping, with results reviewed by medical professionals during the same visit. While the company has completed 100,000 scans across its existing clinics in the UK and Sweden, it has not yet published peer-reviewed studies validating the clinical outcomes or cost-effectiveness of its combined screening approach.

3. Regulatory Status and Market Access

In May 2026, two of Neko’s proprietary devices, Derma-2 and Spectrum-2, received 510(k) clearance from the FDA for specific diagnostic support functions. However, the company classifies its US clinics as preventive health and wellness providers rather than full-service medical practices. Neko’s services are not currently covered by health insurance, requiring customers to pay out-of-pocket. The company advises clients to maintain relationships with their existing healthcare providers for formal diagnosis and treatment. While Neko plans to open additional US locations, it has not yet provided a detailed expansion schedule or confirmed pricing for the American market.